Abstract
AbstractTb3+‐substituted superparamagnetic iron‐oxide‐based nanoparticles (NPs) that can be promising for possible multimodal drug carrier and radiotherapy are presented. These NPs were obtained using a reverse micelle template method with controlled micelle size. The atomic ratio of Tb/Fe ions was found to be very close to that expected from the stoichiometry of the reagents used. Aqueous suspensions of Tb‐doped nanoferrites are emissive with emission peaks characteristic for the Tb3+ dopant. Time‐resolved fluorescence decay data revealed two populations occupying inequivalent matrix sites. Above 80 K the Tb‐doped nanoferrites were superparamagnetic, which is a prerequisite for their use as carriers in magnetic‐field‐driven targeted therapies. The incorporation of up to 15 at.% of Tb3+ in their core resulted in a decrease of magnetization. Nevertheless, this magnetization appears to be sufficient for their use as carriers in an external magnetic field, and, of equal importance, stable isotope 159Tb3+ could be replaced by radioactive 161Tb3+, yielding multimodal NPs, suitable for conjugated therapies such as radiotherapy and magnetothermal therapy, as well as targeted drug delivery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
